These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37335864)

  • 1. Efgartigimod restores muscle function in a humanized mouse model of immune-mediated necrotizing myopathy.
    Julien S; van der Woning B; De Ceuninck L; Briand E; Jaworski T; Roussel G; Zoubaïri R; Allenbach Y; Benveniste O; Drouot L; Boyer O
    Rheumatology (Oxford); 2023 Dec; 62(12):4006-4011. PubMed ID: 37335864
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Bergua C; Chiavelli H; Allenbach Y; Arouche-Delaperche L; Arnoult C; Bourdenet G; Jean L; Zoubairi R; Guerout N; Mahler M; Benveniste O; Drouot L; Boyer O
    Ann Rheum Dis; 2019 Jan; 78(1):131-139. PubMed ID: 30309969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y; Benveniste O; Stenzel W; Boyer O
    Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model.
    Julien S; Vadysirisack D; Sayegh C; Ragunathan S; Tang Y; Briand E; Carrette M; Jean L; Zoubairi R; Gondé H; Benveniste O; Allenbach Y; Drouot L; Boyer O
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009583
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
    Williams B; Horn MP; Banz Y; Feldmeyer L; Villiger PM
    J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy.
    Yang H; Sun C; Ye L; Xu Y; Lin S; Peng Q; Wang G; Lu X
    Arthritis Res Ther; 2024 Sep; 26(1):158. PubMed ID: 39261921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
    Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
    Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
    Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F
    Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
    Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S
    Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of immune-mediated necrotizing myopathies and their treatments.
    Pinal-Fernandez I; Mammen AL
    Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
    Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A
    Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience.
    Klein M; Mann H; Pleštilová L; Zámečník J; Betteridge Z; McHugh N; Vencovský J
    Rheumatology (Oxford); 2015 Nov; 54(11):2010-4. PubMed ID: 26109604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M
    Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues.
    Khoo T; Chinoy H
    Autoimmun Rev; 2023 Dec; 22(12):103468. PubMed ID: 37884200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
    Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.
    Drouot L; Allenbach Y; Jouen F; Charuel JL; Martinet J; Meyer A; Hinschberger O; Bader-Meunier B; Kone-Paut I; Campana-Salort E; Eymard B; Tournadre A; Musset L; Sibilia J; Marie I; Benveniste O; Boyer O;
    Arthritis Res Ther; 2014 Feb; 16(1):R39. PubMed ID: 24484965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.